Literature DB >> 10650913

Real-time PCR-analysis of the cytochrome P450 1B1 codon 432-polymorphism.

T Brüning1, J Abel, B Koch, K Lorenzen, V Harth, S Donat, A Sachinidis, H Vetter, H M Bolt, Y Ko.   

Abstract

The aim of the present study was to develop and validate a rapid assay for genotyping of CYP1B1 codon 432-polymorphism. The described method is a single tube assay and combines both rapid-cycle polymerase chain reaction (PCR) with real-time monitoring by amplification and generation of the melting profiles of an allele-specific fluorescent probe. With this method 300 samples were analysed from healthy, unrelated Germans. Genotype frequency determined for the mutated allele CYP1B1*2 was 0.40. The results show that genotyping of CYP1B1 codon 432-polymorphism with a real-time fluorescence PCR method is a rapid and reliable assay for the analysis of large numbers of samples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10650913     DOI: 10.1007/s002040050631

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  3 in total

1.  Cyp1B1 mRNA expression in correlation to cotinine levels with respect to the Cyp1B1 L432V gene polymorphism.

Authors:  Simone Helmig; Jens Udo Seelinger; Monika Philipp-Gehlhaar; Juliane Döhrel; Joachim Schneider
Journal:  Eur J Epidemiol       Date:  2010-09-10       Impact factor: 8.082

2.  Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study.

Authors:  F D Dick; G De Palma; A Ahmadi; A Osborne; N W Scott; G J Prescott; J Bennett; S Semple; S Dick; P Mozzoni; N Haites; S Bezzina Wettinger; A Mutti; M Otelea; A Seaton; P Soderkvist; A Felice
Journal:  Occup Environ Med       Date:  2007-04-20       Impact factor: 4.402

3.  Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women.

Authors:  K-M Lee; J Abel; Y Ko; V Harth; W-Y Park; J-S Seo; K-Y Yoo; J-Y Choi; A Shin; S-H Ahn; D-Y Noh; A Hirvonen; D Kang
Journal:  Br J Cancer       Date:  2003-03-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.